Aaron Sato
Chief Tech/Sci/R&D Officer presso TWIST BIOSCIENCE CORPORATION
Profilo
Attualmente, Aaron K. Sato è direttore scientifico della Twist Bioscience Corp. Nella sua carriera passata è stato vicepresidente della ricerca alla Sutro Biopharma, Inc., direttore scientifico della LakePharma, Inc., vicepresidente delle scienze proteiche alla Surrozen, Inc., direttore dell'ingegneria anticorpale alla OncoMed Pharmaceuticals, Inc. e direttore senior della ricerca alla Dyax Corp. Aaron K. Sato ha conseguito un dottorato presso il Massachusetts Institute of Technology e una laurea presso l'Università di Puget Sound.
Posizioni attive di Aaron Sato
| Società | Posizione | Inizio |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Aaron Sato
| Società | Posizione | Fine |
|---|---|---|
LakePharma, Inc.
 LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Chief Tech/Sci/R&D Officer | 01/06/2018 |
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2017 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2012 |
| DYAX CORP. | Corporate Officer/Principal | 01/07/2006 |
Formazione di Aaron Sato
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Puget Sound | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Aziende private | 4 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology LakePharma, Inc. operates as a contract research organization which engages in the provision of antibody and protein engineering, cell line development, and protein production. Its services include antibody generation, antibody engineering and production, protein engineering and production, protein conjugation, protein analytics, bioassays, DNA studio, stable cell lines, bio manufacturing and service packages. The company was founded by Hua Tu in September 2009 and is headquartered in Belmont, CA. | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Aaron Sato
